Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors
- PMID: 32867328
- PMCID: PMC7563864
- DOI: 10.3390/jcm9092780
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors
Abstract
We aimed to assess the prevalence of and factors associated with anti- severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) positivity in a large population of adult volunteers from five administrative departments of the Liguria and Lombardia regions. A total of 3609 individuals were included in this analysis. Participants were tested for anti-SARS-CoV-2 antibodies [Immunoglobulin G (IgG) and M (IgM) class antibodies] at three private laboratories (Istituto Diganostico Varelli, Medical Center, and Casa della Salute di Genova). Demographic data, occupational or private exposure to SARS-CoV-2-infected patients, and prior medical history consistent with SARS-CoV-2 infection were collected according to a preplanned analysis. The overall seroprevalence of anti-SARS-CoV-2 antibodies (IgG and/or IgM) was 11.0% [398/3609; confidence interval (CI) 10.0%-12.1%]. Seroprevalence was higher in female inmates than in male inmates (12.5% vs. 9.2%, respectively, p = 0.002), with the highest rate observed among adults aged >55 years (13.2%). A generalized estimating equations model showed that the main risk factors associated with SARS-CoV-2 seroprevalence were the following: an occupational exposure to the virus [Odd ratio (OR) = 2.36; 95% CI 1.59-3.50, p = 0.001], being a long-term care facility resident (OR = 4.53; 95% CI 3.19-6.45, p = 0.001), and reporting previous symptoms of influenza-like illness (OR = 4.86; 95% CI 3.75-6.30, p = 0.001) or loss of sense of smell or taste (OR = 41.00; 95% CI 18.94-88.71, p = 0.001). In conclusion, we found a high prevalence (11.0%) of SARS-CoV-2 infection that is significantly associated with residing in long-term care facilities or occupational exposure to the virus. These findings warrant further investigation into SARS-CoV-2 antibody prevalence among the Italian population.
Keywords: COVID-19; SARS-CoV-2; antibodies; serological test.
Conflict of interest statement
Outside the submitted work, M.B. (Matteo Bassetti) has participated in advisory boards and/or received speaker honoraria from Achaogen, Angelini, Astellas, Bayer, Basilea, BioMeérieux, Cidara, Gilead, Menarini, MSD, Nabriva, Paratek, Pfizer, Roche, Melinta, Shionogi, Tetraphase, VenatoRx, and Vifor and has received study grants from Angelini, Basilea, Astellas, Shionogi, Cidara, Melinta, Gilead, Pfizer, and MSD. Outside the submitted work, D.R.G. reports honoraria from Stepstone Pharma GmbH and unconditional grants from MSD Italia and Correvio Italia. The authors declare no conflict of interest.
Figures

Similar articles
-
Enzyme-Linked Immunosorbent Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgM/IgA and IgG Antibodies Among Healthcare Workers.Cureus. 2020 Sep 6;12(9):e10285. doi: 10.7759/cureus.10285. Cureus. 2020. PMID: 33047077 Free PMC article.
-
Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020.J Clin Med. 2020 Nov 5;9(11):3569. doi: 10.3390/jcm9113569. J Clin Med. 2020. PMID: 33167563 Free PMC article.
-
Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-19.Hepatol Res. 2020 Oct;50(10):1196-1200. doi: 10.1111/hepr.13551. Epub 2020 Aug 14. Hepatol Res. 2020. PMID: 32729953
-
Anti-SARS-CoV-2 Seropositivity Among Medical Students in Copenhagen.Open Forum Infect Dis. 2021 Aug 19;8(8):ofab273. doi: 10.1093/ofid/ofab273. eCollection 2021 Aug. Open Forum Infect Dis. 2021. PMID: 34423066 Free PMC article.
-
SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy).Vaccines (Basel). 2020 Dec 19;8(4):778. doi: 10.3390/vaccines8040778. Vaccines (Basel). 2020. PMID: 33352743 Free PMC article.
Cited by
-
Seroprevalence of SARS-CoV-2 in a Large Cohort of Italian Police Officers.Int J Environ Res Public Health. 2021 Nov 20;18(22):12201. doi: 10.3390/ijerph182212201. Int J Environ Res Public Health. 2021. PMID: 34831958 Free PMC article.
-
Risk factors of SARS-CoV-2 seroprevalence among hospital employees in Italy: a single-centre study.Intern Med J. 2021 Jul;51(7):1049-1059. doi: 10.1111/imj.15201. Epub 2021 Apr 26. Intern Med J. 2021. PMID: 33876536 Free PMC article.
-
Serological surveillance reveals a high exposure to SARS-CoV-2 and altered immune response among COVID-19 unvaccinated Cameroonian individuals.PLOS Glob Public Health. 2024 Feb 12;4(2):e0002380. doi: 10.1371/journal.pgph.0002380. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 38346064 Free PMC article.
-
Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic.Int J Infect Dis. 2021 Jun;107:116-120. doi: 10.1016/j.ijid.2021.04.059. Epub 2021 Apr 20. Int J Infect Dis. 2021. PMID: 33892190 Free PMC article.
-
Impact of the Second Epidemic Wave of SARS-CoV-2: Increased Exposure of Young People.Front Public Health. 2021 Jul 26;9:715192. doi: 10.3389/fpubh.2021.715192. eCollection 2021. Front Public Health. 2021. PMID: 34381756 Free PMC article.
References
-
- [(accessed on 30 April 2020)]; Available online: http://www.salute.gov.it/portale/nuovocoronavirus/
LinkOut - more resources
Full Text Sources
Miscellaneous